Pharma Journalist -

CARISMA Therapeutics Inc., a clinical stage biopharmaceutical company focused on discovering and developing innovative immunotherapies, announced it has established a multi-year…
Read More...

SMi Reports: SMi Group are delighted to announce Christian Dechant, Director Primary Packaging & Process Development, Boehringer Ingelheim will be speaking at the Injectable Drug…
Read More...

Samsung Biologics and TG Therapeutics announced an expansion of a large-scale contract manufacturing deal for the supply of TG Therapeutics' ublituximab, an investigational anti-CD20…
Read More...

SMi reports: Registration is now open for SMi’s Aseptic Processing Conference, which will convene in London on 20th and 21st September 2021. SMi Group are proud to announce the…
Read More...

Zenith Epigenetics Ltd. a clinical stage biotechnology company focused on the development of novel epigenetic combination therapies for the treatment of cancers, announces it has…
Read More...

Vertex Pharmaceuticals Incorporated and Obsidian Therapeutics announced that the two companies have entered into a strategic research collaboration and licensing agreement focused on…
Read More...

GlaxoSmithKline plc announced that the US Food and Drug Administration (FDA) has approved JEMPERLI (dostarlimab-gxly), a programmed death receptor-1 (PD-1) blocking antibody, based on…
Read More...

Claritas Pharmaceuticals, Inc. announced that it has entered into an agreement with CMAX Clinical Research Pty Ltd (“CMAX”) to conduct a randomized, placebo-controlled, single-blind,…
Read More...

Nanoform Finland Plc, an innovative nanoparticle medicine enabling company, and Aprecia, the 3DP (three-dimensional printing) pharmaceutical company, announce that they are exploring…
Read More...

A Phase 2/3 trial to evaluate a new fully-human polyclonal antibody therapeutic targeted to SARS-CoV-2, called SAB-185, has begun enrolling non-hospitalized people with mild or moderate…
Read More...